Kamada (KMDA) Stock Analysis

Kamada (KMDA) is a publicly traded company in the HEALTHCARE sector. It trades at $7.70, carries a market capitalization of $445.18M, a price-to-earnings ratio of 22.00, a dividend yield of 0.03%. This page summarizes the public market data, fundamentals, and frequently asked questions for KMDA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $7.70
• Market Cap: $445.18M
• P/E Ratio: 22.00
• EPS: $0.35
• Dividend Yield: 0.03%
• 52-Week High: $9.07
• 52-Week Low: $6.31

Market Sentiment

Kamada currently has a Bullish sentiment score of 0.52.

About Kamada

Kamada Ltd. is a biopharmaceutical company based in Rehovot, Israel, specializing in the development and commercialization of plasma-derived protein therapies for rare diseases. The company has established a robust pipeline targeting significant unmet medical needs, leveraging its proprietary technology to yield high-quality therapeutic solutions. With a strong commitment to innovation and a strategic focus on advancing patient care, Kamada presents a compelling investment opportunity in the ...

GNG Research Analysis

GNG Research scores Kamada (KMDA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for KMDA.

Frequently Asked Questions

What is KMDA's current dividend yield?

Kamada (KMDA) has a current dividend yield of 0.03%.

Does KMDA pay dividends?

Yes, Kamada pays dividends with a current yield of 0.03%.

What is KMDA's P/E ratio?

Kamada has a price-to-earnings (P/E) ratio of 22.00.

What is KMDA's market cap?

Kamada (KMDA) has a market capitalization of $445.18M with a current stock price of $7.70.